These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7979300)

  • 1. Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda.
    Van Dyck E; Bogaerts J; Smet H; Tello WM; Mukantabana V; Piot P
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1647-8. PubMed ID: 7979300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.
    Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole.
    Bogaerts J; Kestens L; Martinez Tello W; Akingeneye J; Mukantabana V; Verhaegen J; Van Dyck E; Piot P
    Clin Infect Dis; 1995 Apr; 20(4):924-30. PubMed ID: 7795096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.
    Motley M; Sarafian SK; Knapp JS; Zaidi AA; Schmid G
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1639-43. PubMed ID: 1416845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
    Ismaeel NA
    Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance of Haemophilus ducreyi.
    Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
    Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.
    Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C
    J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.
    Bilgeri YR; Ballard RC; Duncan MO; Mauff AC; Koornhof HJ
    Antimicrob Agents Chemother; 1982 Oct; 22(4):686-8. PubMed ID: 6983858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa.
    Abeck D; Johnson AP; Dangor Y; Ballard RC
    J Antimicrob Chemother; 1988 Oct; 22(4):437-44. PubMed ID: 3264554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.
    Aldridge KE; Cammarata C; Martin DH
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1986-8. PubMed ID: 8239617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First reported case of chancroid in the Czech Republic.
    Rob F; Jilich D; Lásiková Š; Křížková V; Hercogová J
    Int J STD AIDS; 2018 Nov; 29(11):1127-1129. PubMed ID: 29749871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Haemophilus ducreyi.
    Hammond GW; Lian CJ; Wilt JC; Ronald AR
    Antimicrob Agents Chemother; 1978 Apr; 13(4):608-12. PubMed ID: 307364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chancroid and granuloma inguinale.
    Ronald AR; Plummer FA
    Clin Lab Med; 1989 Sep; 9(3):535-43. PubMed ID: 2676322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.
    Dangor Y; Miller SD; Exposto Fda L; Koornhof HJ
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1458-60. PubMed ID: 3264133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of chancroid.
    Schmid GP
    JAMA; 1986 Apr; 255(13):1757-62. PubMed ID: 3512872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative in-vitro activity of twelve 4-quinolone antimicrobials against Haemophilus ducreyi.
    Wall RA; Mabey DC; Bello CS; Felmingham D
    J Antimicrob Chemother; 1985 Aug; 16(2):165-8. PubMed ID: 3877717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo activity of combination antimicrobial agents on Haemophilus ducreyi.
    Roy-Leon JE; Lauzon WD; Toye B; Singhal N; Cameron DW
    J Antimicrob Chemother; 2005 Sep; 56(3):552-8. PubMed ID: 16046468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chancroid, 1989.
    Schmid GP
    Rev Infect Dis; 1990; 12 Suppl 6():S580-9. PubMed ID: 2201074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethoprim sulphamoxole in the treatment of chancroid. Comparison of two single dose treatment regimens with a five day regimen.
    Dylewski J; Nsanze H; D'Costa L; Slaney L; Ronald A
    J Antimicrob Chemother; 1985 Jul; 16(1):103-9. PubMed ID: 3876325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus ducreyi.
    Daly JA
    Infect Control; 1985 May; 6(5):203-5. PubMed ID: 3888902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.